NYHA class III/IV Dilated (ischemic or idiopathic) cardiomyopathy Sinus rhythm >/= 55 bpm QRS >/= 120 ms PR interval >/= 150 ms ...

Factors portending the greatest risk for cardiovascular death in control patients were inflammation (baseline plasma high-sensitivity C-reactive protein ≥2 mg/L; p=0.003) and ischemic HFrEF etiology ...

The study enrolled 4128 patients 60 years and older with NYHA class II-IV symptoms and ejection fraction ≥45% who were hospitalized for heart failure during the last 6 months or had persistent ...

1 Department of Internal Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States 2 Heart and Vascular Center ... The average age was 70, with 69.7% being male, and 74.8% classified as ...

The effect of once-weekly exenatide on heart failure (HF) outcomes is modified by left ventricular ejection fraction ... and HR, 1.84; [95% CI, 0.95-3.59] in NYHA class III/IV; P interaction =.062).

CHICAGO, IL—A novel noninvasive intracardiac pressure monitoring device powered by artificial intelligence (AI) could be a potential alternative to invasive monitoring in patients with heart failure ...

Aldosterone is an important mediator in the pathogenesis of heart failure, and increased plasma aldosterone levels are associated with a poor prognosis. Aldosterone-receptor blocking drugs can ...

Most patients experienced severe TR and high symptom burden, with 78.0% classified as New York Heart Association (NYHA) class III/IV and 63.4% having a history of heart failure hospitalisation within ...

DEAR DR. ROACH: My husband is 73 and was diagnosed with heart failure and a severely dilated left ventricle. At the time, he was pumping 10 liters per minute. He had a proBNP natriuretic peptide ...

New Gene Therapy Reverses Heart Failure in Large Animal Model Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart ...